Skip to main content

GeneOhm Licenses Sequencing Technology from University of Rochester

NEW YORK, Feb. 16 (GenomeWeb News) - GeneOhm Sciences has licensed a nucleic acid-synthesis and -amplification technology from the e Universityof Rochester, the company said today.


The non-exclusive license will help GeneOhm develop molecular diagnostic assays to identify gene sequences to certain undisclosed diseases, the company said.

The nucleic acid synthesis technology developed at the Universityof Rochester"offers the potential to differentiate and amplify specific DNA sequences faster and at a lower cost than other methods," GeneOhm said.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.